Skip to main content

Day: August 5, 2020

AgEagle Aerial Systems to Host Corporate Update on Tuesday, August 18, 2020 at 11:00 AM ET

NEODESHA, Kan., Aug. 05, 2020 (GLOBE NEWSWIRE) — AgEagle Aerial Systems Inc. (NYSE American: UAVS), an industry leading provider of UAVs and advanced aerial imagery, data collection and analytics solutions, will host a webcast on Tuesday, August 18, 2020 at 11:00 a.m. Eastern time to provide a corporate update and discuss recent operational highlights.AgEagle CEO Michael Drozd and CFO Nicole Fernandez-McGovern will host the conference call. Investors and analysts are encouraged to submit questions they would like management to address during the discussion via email to UAVS@gatewayir.com by Friday, August 14, 2020 at 5:00 p.m. Eastern time.Webcast Date: Tuesday, August 18, 2020Time: 11:00 a.m. Eastern time (10:00 a.m. Central time)Webcast Link: https://www.webcaster4.com/Webcast/Page/2160/36280The corporate update will be broadcast...

Continue reading

Yield10 Bioscience Announces Spring Planting of 50 Acres of Wild-Type Spring Camelina to Support Business Development Plans

WOBURN, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that it established 50 acres of spring Camelina under contract with a grower in Montana in the second quarter of 2020. This is a business development activity necessary to gain experience in establishing the value chain for producing Camelina sativa seed at large scale as a source of new crop products. The objective of this activity was to gain experience in seed bulk-up, grower contracts, logistics and handling of harvested seed, including toll crushing, and to produce quantities of oil and protein meal for customer sampling. The crop has reached maturity and is currently drying down with harvesting expected in the weeks ahead.“The successful establishment of spring Camelina at the 50 acre...

Continue reading

red violet Introduces Geospatial Search and Information Retrieval Technology Within Leading idiCORE Investigative Platform

BOCA RATON, Fla., Aug. 05, 2020 (GLOBE NEWSWIRE) — Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, today announced the beta release of its geospatial search and information retrieval technology, available only through the idiCORE™ platform of red violet subsidiary Interactive Data, LLC (IDI).By combining geohash indexing with wild card and feature filtering techniques, the technology enables users to leverage data in new and insightful ways. Powerful cross-linking of entities in IDI’s massive data repository enables efficient exploration of people, businesses, assets, and interrelationships, delivering greater and otherwise unattainable intelligence, including advanced understanding of both current and historical geographic relationships.Initially applied to IDI’s comprehensive motor vehicle...

Continue reading

Nicholas Financial, Inc. Announces New Company Logo and 35th Anniversary

CLEARWATER, Fla., Aug. 05, 2020 (GLOBE NEWSWIRE) — Nicholas Financial, Inc. (NASDAQ: NICK) – an industry leading branch-based subprime auto lender focused on servicing the needs of the local independent dealer and borrowing customer – announced the launch of their new company logo.  The refreshed image reflects Nicholas’ current renaissance and symbolizes its focus on the future as it proudly celebrates its 35th Anniversary.“We are excited to unveil our new logo and retire the world map logo that has represented our brand since 1985,” said Doug Marohn, president and CEO of Nicholas Financial.  “A more modern, streamlined logo is just one small example of our renewed commitment to improvement, success and excellence.”After careful consideration, the Company chose a new logo that reflects a more modern look and captures its mission...

Continue reading

Entera Bio to Present at BTIG’s Virtual Biotechnology Conference

BOSTON and JERUSALEM, Aug. 05, 2020 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced that members of its management team will participate virtually in the BTIG Biotechnology Conference on Monday, August 10, 2020 at 12:30 p.m. EDT. To access a live webcast of the fireside chat on the “Investor Relations” page of Entera’s website, please click here. A replay of the webcast will be archived on Entera’s website for approximately 45 days following the presentation.About Entera BioEntera is a leader in the development of orally delivered macromolecule therapeutics for use in areas with significant unmet medical need where adoption of injectable therapies is limited due to cost, convenience and compliance challenges for patients. The Company’s proprietary,...

Continue reading

Allena Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Business Update

— Expanding URIROX-2 Trial Sites; Interim Analysis on Track for the First Quarter of 2022 –-— Initiated Phase 1 Clinical Trial of ALLN-346; Initial Data Expected in the Fourth Quarter of 2020 –-— Raised Gross Proceeds of $22.7M Through Two Public Offerings, Extending Cash Runway Beyond the Second Quarter of 2021 –-NEWTON, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) — Allena Pharmaceuticals (NASDAQ:ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today reported financial results for the second quarter ended June 30, 2020 and provided a business update.“In concert with our recent financings, our team has moved quickly to implement planned activities across our portfolio,...

Continue reading

Vericel Reports Second Quarter 2020 Financial Results

Product Revenues of $20.0 Million Reported for the Second QuarterConference Call Today at 8:30am Eastern TimeCAMBRIDGE, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today reported financial results and business highlights for the second quarter ended June 30, 2020.Total net product revenues of $20.0 million, compared to $26.2 million in the second quarter of 2019;MACI® net revenue of $15.1 million and Epicel® net revenue of $4.9 million;Gross margin of 57%, compared to gross margin of 66% in the second quarter of 2019;Net loss of $8.3 million, or $0.18 per share, compared to $19.8 million, or $0.45 per share, in the second quarter of 2019, which included the $17.5 million upfront license payment to MediWound Ltd. for...

Continue reading

Pacific Mercantile Bancorp Reports Second Quarter 2020 Operating Results

Second Quarter SummaryNet income of $1.9 million, or $0.08 per fully diluted shareFunded $280.3 million of Paycheck Protection Program (“PPP”) loans for almost 700 companies representing over 30,000 employeesExecution of PPP was the primary driver for the increase in interest income from loans over last quarter of $1.5 million, or 10.9%, and an increase in total interest income of $811 thousand, or 5.5%Ongoing focus on reducing costs of deposits in combination with the Federal Reserve’s rate cuts resulted in a decrease in interest expense over last quarter of $1.0 million, or 31.4%Implementation of cost savings initiatives contributed to a reduction in noninterest expense over last quarter by $786 thousand, or 8.1%Provision for loan and lease losses of $2.9 million primarily as a result of net charge-offs of $2.2 million, an increase...

Continue reading

Malvern Bancorp, Inc. Reports Third Fiscal Quarter 2020 Results

PAOLI, Pa., Aug. 05, 2020 (GLOBE NEWSWIRE) — Malvern Bancorp, Inc. (NASDAQ: MLVF) (the “Company”), the parent company of Malvern Bank, National Association (“Malvern” or the “Bank”), today reported operating results for the third fiscal quarter ended June 30, 2020.   Net income for the quarter ended June 30, 2020 amounted to $1.5 million, or $0.19 per fully diluted common share, compared with net income of $2.7 million, or $0.35 per fully diluted common share, for the quarter ended June 30, 2019. The decreases in net income and diluted earnings per share from the third quarter of 2019 were primarily due to an increase in the provision for loan losses and a decrease in net interest income. The Company recorded a provision for loan losses of $435,000 for the quarter ended June 30, 2020, an increase of $379,000 compared to the quarter...

Continue reading

XDD Acquires Anexsys Group Limited in London to Expand International Presence in UK

MISSION, Kan., Aug. 05, 2020 (GLOBE NEWSWIRE) — Xact Data Discovery (XDD), a leading international provider of eDiscovery, data management and managed review services for law firms and corporations, announces the acquisition of Anexsys Group Limited, an eDiscovery services company based in London, UK. David Moran, XDD President and COO, states, “Complementing our recent domestic acquisitions, adding Anexsys to the XDD family enables XDD to expand eDiscovery, Forensics and Managed Review services in the UK. Based strategically in London, UK, the Anexsys team has earned a solid reputation for providing exemplary eDiscovery consultancy services to a wide variety of law firms, corporations and government agencies. Mirroring XDD’s customer-centric culture, we look forward to jointly servicing clients as we continue to expand our footprint...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.